Haemonetics (HAE) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Haemonetics Revenue Highlights

Latest Revenue (Y)

$1.31B

Latest Revenue (Q)

$336.17M

Main Segment (Y)

Service

Main Geography (Y)

UNITED STATES

Haemonetics Revenue by Period

Haemonetics Revenue by Year

Date	Revenue	Change
2024-03-30	$1.31B	12.01%
2023-04-01	$1.17B	17.67%
2022-04-02	$993.20M	14.10%
2021-04-03	$870.46M	-11.94%
2020-03-28	$988.48M	2.16%
2019-03-30	$967.58M	7.04%
2018-03-31	$903.92M	2.01%
2017-04-01	$886.12M	-2.59%
2016-04-02	$909.67M	-0.08%
2015-03-28	$910.37M	-3.00%
2014-03-29	$938.51M	5.22%
2013-03-30	$891.99M	22.55%
2012-03-31	$727.84M	7.56%
2011-04-02	$676.69M	4.84%
2010-04-03	$645.43M	7.95%
2009-03-28	$597.88M	15.77%
2008-03-29	$516.44M	14.86%
2007-03-31	$449.61M	7.12%
2006-04-01	$419.73M	9.42%
2005-04-02	$383.60M	5.32%
2004-04-03	$364.23M	8.09%
2003-03-29	$336.96M	5.31%
2002-03-30	$319.97M	8.88%
2001-03-31	$293.86M	5.73%
2000-04-01	$277.92M	-1.48%
1999-04-03	$282.10M	-1.29%
1998-03-28	$285.80M	-7.75%
1997-03-29	$309.80M	11.36%
1996-03-30	$278.20M	6.02%
1995-03-31	$262.40M	5.64%
1994-03-31	$248.40M	-

Haemonetics generated $1.31B in revenue during NA 2024, up 12.01% compared to the previous quarter, and up 135.29% compared to the same period a year ago.

Haemonetics Revenue by Quarter

Date	Revenue	Change
2024-06-29	$336.17M	-2.07%
2024-03-30	$343.29M	2.09%
2023-12-30	$336.25M	5.68%
2023-09-30	$318.18M	2.20%
2023-07-01	$311.33M	2.27%
2023-04-01	$304.42M	-0.29%
2022-12-31	$305.30M	2.63%
2022-10-01	$297.49M	13.78%
2022-07-02	$261.46M	-1.34%
2022-04-02	$265.00M	2.01%
2022-01-01	$259.77M	8.28%
2021-10-02	$239.90M	4.97%
2021-07-03	$228.53M	1.55%
2021-04-03	$225.03M	-6.38%
2020-12-26	$240.37M	14.74%
2020-09-26	$209.49M	7.11%
2020-06-27	$195.58M	-17.99%
2020-03-28	$238.49M	-7.91%
2019-12-28	$258.97M	2.54%
2019-09-28	$252.57M	5.92%
2019-06-29	$238.45M	-4.35%
2019-03-30	$249.29M	0.78%
2018-12-29	$247.36M	2.39%
2018-09-29	$241.58M	5.33%
2018-06-30	$229.35M	-1.80%
2018-03-31	$233.55M	-0.21%
2017-12-30	$234.04M	3.85%
2017-09-30	$225.38M	6.84%
2017-07-01	$210.95M	-7.50%
2017-04-01	$228.07M	0.10%
2016-12-31	$227.84M	3.45%
2016-10-01	$220.25M	4.90%
2016-07-02	$209.96M	-13.66%
2016-04-02	$243.19M	4.20%
2015-12-26	$233.38M	6.23%
2015-09-26	$219.69M	2.94%
2015-06-27	$213.41M	-5.77%
2015-03-28	$226.48M	-2.31%
2014-12-27	$231.83M	1.87%
2014-09-27	$227.58M	1.38%
2014-06-28	$224.49M	-6.89%
2014-03-29	$241.09M	-0.42%
2013-12-28	$242.12M	2.70%
2013-09-28	$235.75M	7.38%
2013-06-29	$219.54M	-12.16%
2013-03-30	$249.94M	1.03%
2012-12-29	$247.40M	13.39%
2012-09-29	$218.18M	23.63%
2012-06-30	$176.47M	-5.46%
2012-03-31	$186.67M	-2.35%
2011-12-31	$191.16M	6.53%
2011-10-01	$179.44M	5.20%
2011-07-02	$170.57M	0.32%
2011-04-02	$170.03M	-3.82%
2011-01-01	$176.79M	5.97%
2010-10-02	$166.83M	2.33%
2010-07-03	$163.04M	-3.59%
2010-04-03	$169.10M	2.38%
2009-12-26	$165.17M	5.16%
2009-09-26	$157.07M	1.94%
2009-06-27	$154.09M	1.11%
2009-03-28	$152.40M	-1.96%
2008-12-27	$155.45M	6.53%
2008-09-27	$145.92M	1.25%
2008-06-28	$144.12M	3.88%
2008-03-29	$138.74M	-

Haemonetics generated $336.17M in revenue during Q1 2025, up -2.07% compared to the previous quarter, and up 110.43% compared to the same period a year ago.

Haemonetics Revenue Breakdown

Haemonetics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 24	Apr 23	Apr 22	Apr 21	Mar 20
Service	$21.63M	$21.42M	$20.81M	$20.76M	$19.83M
Hospital	-	$378.11M	$329.43M	$216.58M	$198.42M
Blood Center	-	$226.82M	$236.16M	$239.61M	$252.83M
Plasma	-	$563.73M	$427.61M	$414.27M	$537.23M

Haemonetics's latest annual revenue breakdown by segment (product or service), as of Mar 24: Service (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Dec 22	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Apr 21	Dec 20	Sep 20	Jun 20	Dec 19	Sep 19	Jun 19	Dec 18	Sep 18
Hospital	$138.38M	$48.38M	$48.99M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Blood Center	$68.80M	$72.92M	$67.16M	$68.24M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Plasma	$138.56M	$83.75M	$131.82M	$124.35M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	-	$5.23M	$5.59M	$5.04M	$5.77M	$5.37M	$5.41M	$5.14M	$5.44M	$4.95M	$5.27M	$4.97M	$5.34M	$5.08M	$5.20M	$5.28M	$4.87M	-	-	-
Blood Center Products and Services	-	-	-	-	-	$58.27M	$61.90M	$52.92M	$59.44M	$59.93M	$57.75M	$62.79M	$59.23M	$60.67M	$66.13M	$65.61M	$59.91M	-	-	-
Hospital Products and Services	-	-	-	-	-	$93.13M	$92.43M	$90.19M	$83.98M	$77.89M	$80.27M	$54.07M	$52.54M	$46.20M	$51.61M	$51.10M	$48.80M	-	-	-
Plasma Products and Services	-	-	-	-	-	$153.90M	$143.16M	$118.35M	$116.35M	$102.08M	$90.51M	$123.51M	$97.71M	$88.71M	$141.23M	$135.85M	$129.75M	-	-	-

Haemonetics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Plasma (40.08%), Hospital (40.02%), and Blood Center (19.90%).

Haemonetics Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 24	Apr 23	Apr 22	Apr 21	Mar 20
Asia	$107.54M	$104.14M	$110.80M	$105.82M	$109.30M
UNITED STATES	$970.01M	$842.90M	$639.32M	$522.61M	$646.20M
Other Country or Region	$13.28M	$3.65M	$3.99M	$5.28M	$7.42M
JAPAN	$58.09M	$61.30M	$75.56M	$77.68M	$72.22M
Europe	$160.14M	$156.68M	$163.52M	$159.08M	$153.35M
Hospital	-	-	$329.43M	-	-
Blood Center	-	-	$236.16M	-	-
Service	-	-	$20.81M	-	-
Plasma	-	-	$427.61M	-	-

Haemonetics's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (74.10%), Europe (12.23%), Asia (8.21%), JAPAN (4.44%), and Other Country or Region (1.01%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Dec 22	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Dec 20	Sep 20	Jun 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Europe	$41.99M	$45.05M	$37.03M	$38.67M	$39.39M	$39.10M	$41.85M	$40.46M	$41.54M	$41.18M	$43.34M	$41.87M	$38.65M	$43.02M	$40.98M	$38.07M	$36.75M	$40.98M	$39.10M	-
JAPAN	$16.42M	$16.48M	$14.82M	$15.01M	$11.77M	$15.55M	$15.13M	$13.88M	$19.92M	$18.81M	$17.22M	$20.85M	$19.64M	$16.83M	$19.27M	$20.38M	$15.47M	$17.98M	$17.73M	$17.17M
Other Country or Region	$5.27M	$9.15M	$2.65M	$426.00K	$1.06M	$1.09M	$921.00K	$703.00K	$609.00K	$1.03M	$992.00K	$986.00K	$1.04M	$2.33M	$2.04M	$2.04M	$1.22M	$2.02M	$1.81M	-
UNITED STATES	$256.06M	$245.78M	$250.80M	$236.34M	$237.07M	$224.10M	$211.72M	$182.00M	$167.27M	$152.11M	$141.03M	$147.61M	$123.98M	$111.01M	$167.24M	$161.88M	$156.38M	$157.46M	$152.93M	-
Asia	$25.77M	$26.83M	$30.93M	$27.73M	$22.04M	$25.45M	$27.86M	$24.42M	$30.43M	$26.77M	$25.95M	$29.05M	$26.17M	$22.38M	$29.44M	$30.19M	$28.64M	$29.17M	$30.57M	-
EMEA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$46.47M	-	-
Americas Blood Center and Hospital and Asia - Pacific	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$86.48M	-	-
North America Plasma	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$100.53M	-	-

Haemonetics's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (74.11%), Europe (12.15%), Asia (7.46%), JAPAN (4.75%), and Other Country or Region (1.52%).

Haemonetics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
HOLX	Hologic	$4.03B	$1.01B
COO	Cooper Companies	$3.59B	$1.00B
ATR	AptarGroup	$3.49B	$909.29M
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M
NVST	Envista	$2.57B	$884.70M
ICUI	ICU Medical	$2.26B	$589.13M
HAE	Haemonetics	$1.31B	$336.17M
MMSI	Merit Medical Systems	$1.26B	$339.85M
ATRC	AtriCure	$399.25M	$115.91M
ANGO	AngioDynamics	$303.91M	$67.49M
AKYA	Akoya Biosciences	$96.63M	$18.81M
ATRI	Atrion	-	$48.77M

HAE Revenue FAQ

What is Haemonetics’s yearly revenue?

Haemonetics's yearly revenue for 2024 was $1.31B, representing an increase of 12.01% compared to 2023. The company's yearly revenue for 2023 was $1.17B, representing an increase of 17.67% compared to 2022. HAE's yearly revenue for 2022 was $993.2M, representing an increase of 14.10% compared to 2021.

What is Haemonetics’s quarterly revenue?

Haemonetics's quarterly revenue for Q1 2025 was $336.17M, a -2.07% decrease from the previous quarter (Q4 2024), and a 7.98% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $343.29M, a 2.09% increase from the previous quarter (Q3 2024), and a 12.77% increase year-over-year (Q4 2023). HAE's quarterly revenue for Q3 2024 was $336.25M, a 5.68% increase from the previous quarter (Q2 2024), and a 10.14% increase year-over-year (Q3 2023).

What is Haemonetics’s revenue growth rate?

Haemonetics's revenue growth rate for the last 3 years (2022-2024) was 31.80%, and for the last 5 years (2020-2024) was 32.43%.

What are Haemonetics’s revenue streams?

Haemonetics's revenue streams in r 24 are Service

What is Haemonetics’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Haemonetics was Service. This segment made a revenue of $21.63M, representing 100.00% of the company's total revenue.